Cancer drug prices likely to fall as govt caps trade margins at 30%
FROM THE WIRE · THEHINDUBUSINESSLINE.COM
India caps trade margins on non-scheduled anti-cancer drugs at 30% of MRP, promising significant price cuts and savings for patients.
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishIndia caps trade margins on non-scheduled cancer drugs, reducing prices but potentially pressuring pharma company margins.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01India caps trade margins on non-scheduled anti-cancer drugs at 30% of MRP.
- 02The measure promises significant price cuts for patients.
- 03It could generate substantial savings for cancer drug consumers.